In this podcast, Joseph Solomkin, MD, answers our questions about the IGNITE4 trial, which evaluated eravacycline vs meropenem for the treatment of intra-abdominal infections among acutely hospitalized patients. More at: www.consultant360.com/infectious-diseases.
